<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.1.0//EN//XML?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName art510.dtd?>
  <?SourceDTD.Version 5.1.0?>
  <?ConverterInfo.XSLTName elsevier2nlm.xsl?>
  <?ConverterInfo.Version 1?>
  <?origin publisher?>
  <?FILEmeta_JAER503 xml ?>
  <?FILEmain xml ?>
  <?FILEgr1 jpg ?>
  <?FILEgr2 jpg ?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Adv Enzyme Regul</journal-id>
      <journal-title>Advances in Enzyme Regulation</journal-title>
      <issn pub-type="ppub">0065-2571</issn>
      <issn pub-type="epub">1873-2437</issn>
      <publisher>
        <publisher-name>Pergamon Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2877797</article-id>
      <article-id pub-id-type="pmid">19896968</article-id>
      <article-id pub-id-type="publisher-id">JAER503</article-id>
      <article-id pub-id-type="doi">10.1016/j.advenzreg.2009.10.006</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Localization, regulation and function of Type II phosphatidylinositol 5-phosphate 4-kinases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Clarke</surname>
            <given-names>Jonathan H.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Michael</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Irvine</surname>
            <given-names>Robin F.</given-names>
          </name>
          <email>rfi20@cam.ac.uk</email>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
      </contrib-group>
      <aff>
        <addr-line>Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author. <email>rfi20@cam.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <year>2010</year>
      </pub-date>
      <volume>50</volume>
      <issue>1</issue>
      <fpage>12</fpage>
      <lpage>18</lpage>
      <history/>
      <permissions>
        <copyright-statement>&#xC2;&#xA9; 2010 Elsevier Ltd.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>Elsevier Ltd</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>The variety of form and function in inositides (inositol lipids and phosphates) stems largely from the degree and isomeric specificity of phosphorylation of their common inositol ring. Thus their synthesis, and its differential regulation, lie primarily in the large family of kinases that phosphorylate the inositol ring. In a previous review in this publication (<xref rid="bib13" ref-type="bibr">Irvine et&#xA0;al., 2006</xref>) we addressed the inositol phosphate kinases, with a specific focus on the Ins(1,4,5)<italic>P</italic><sub>3</sub> 3-kinase family. Here we turn to the inositol lipid kinases, with a specific focus on the phosphatidylinositol phosphate kinases. These are the family of enzymes that synthesize phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)<italic>P</italic><sub>2</sub>) (<xref rid="fig1" ref-type="fig">Fig.&#xA0;1</xref>). The Type I enzymes (EC 2.7.1.68) are now known to catalyze the major route of PtdIns(4,5)<italic>P</italic><sub>2</sub> synthesis, the 5-phosphorylation of PtdIns4<italic>P</italic> (<xref rid="bib21" ref-type="bibr">Rameh et&#xA0;al., 1997</xref>), and are here abbreviated as Type I PtdIns4<italic>P</italic> 5-kinases (PtdIns4<italic>P</italic> 5-kinases I&#x3B1;, I&#x3B2; and I&#x3B3;). The Type II enzymes (EC 2.7.1.149) are 4-kinases (<xref rid="bib21" ref-type="bibr">Rameh et&#xA0;al., 1997</xref>), whose preferred substrate (<xref rid="bib21 bib18 bib25" ref-type="bibr">Rameh et&#xA0;al., 1997; Morris et&#xA0;al., 2000; Roberts et&#xA0;al., 2005</xref>) is PtdIns5<italic>P</italic>. They will be abbreviated here as PtdIns5<italic>P</italic> 4-kinases II&#x3B1;, II&#x3B2; and II&#x3B3;.</p>
    </sec>
    <sec id="sec2">
      <title>Type II PtdIns5<italic>P</italic> 4-kinases</title>
      <sec id="sec2.1">
        <title>Type II PtdIns5<italic>P</italic> 4-kinases &#x2013; basic functions</title>
        <p>Although there has been some discussion about the potential functions of the Type II enzymes, there is an emerging consensus that their major function is to regulate the levels of their substrate, PtdIns5<italic>P</italic>. The amount of PtdIns(4,5)<italic>P</italic><sub>2</sub> that they will synthesize relative to the Type I enzymes is likely to be small (mostly because PtdIns5<italic>P</italic> is present at much lower levels than PtdIns4<italic>P</italic> (<xref rid="bib25" ref-type="bibr">Roberts et&#xA0;al., 2005</xref>)). Also, the recent discovery and cloning in Majerus' lab of two isoforms of PtdIns(4,5)<italic>P</italic><sub>2</sub> 4-phosphatase (EC 3.1.3.78) (<xref rid="bib26 bib28" ref-type="bibr">Ungewickell et&#xA0;al., 2005; Zou et&#xA0;al., 2007</xref>), one of which is partly nuclear (<xref rid="bib28" ref-type="bibr">Zou et&#xA0;al., 2007</xref>) (see below for the significance of this) generates a very plausible cycle for the generation of PtdIns5<italic>P</italic> (by a PtdIns(4,5)<italic>P</italic><sub>2</sub> 4-phosphatase) and its removal (by a Type II PtdIns5<italic>P</italic> 4-kinase). <xref rid="bib17" ref-type="bibr">Lecompte et&#xA0;al. (2008)</xref> have suggested an interesting evolutionary pathway for the appearance of this cycle &#x2013; that PtdIns5<italic>P</italic> generation and removal may occur by different routes involving different combinations of enzymes (e.g. from PtdIns <italic>via</italic> Type III PtdIns3<italic>P</italic> 5-kinase and myotubularin) and that the PtdIns(4,5)<italic>P</italic><sub>2</sub> 4-phosphatase/Type II PtdIns5<italic>P</italic> 4-kinase &#x2018;cycle&#x2019; may be the latest of these to evolve, and is confined to metazoans. It is worth noting in this context that the significance of a PTEN homologue that is a 5-phosphatse (EC 3.1.3.36), but very specific for PtdIns5<italic>P</italic> (<xref rid="bib19" ref-type="bibr">Pagliarini et&#xA0;al., 2004</xref>), remains to be explored fully &#x2013; is this an alternative way of removing PtdIns5<italic>P</italic>, and if so, how does it fit in with the Type II PtdIns5<italic>P</italic> 4-kinases?</p>
      </sec>
      <sec id="sec2.2">
        <title>PtdIns5<italic>P</italic></title>
        <p>The functions of PtdIns5<italic>P</italic> are being actively explored, and it seems likely that our list of these is far from complete. This is a pertinent place to point out an error in our description of the mass assay for PtdIns5<italic>P</italic>, which we described in <xref rid="bib25" ref-type="bibr">Roberts et&#xA0;al. (2005)</xref>. This was a refinement of the original assay (<xref rid="bib18" ref-type="bibr">Morris et&#xA0;al., 2000</xref>), and included, after loading the neomycin beads with lipids, a prior rinse with &#x2018;50&#xA0;mM Ammonium formate&#x2019;, before two elutions of inositol lipids with &#x2018;2&#xA0;M TEAB&#x2019; (Triethylammonium bicarbonate). Both these two solutions were described as if they were made up in water, but they should of course have been described as being mixed with chloroform and methanol as with the other bead-elution solutions used in this protocol. Thus they are respectively: CHCl<sub>3</sub>:CH<sub>3</sub>OH:Ammonium Formate 5:10:2 by volume (final concentration of formate 50&#xA0;mM); and CHCl<sub>3</sub>:CH3OH:2&#xA0;M TEAB 5:10:2 by volume (final concentration of TEAB 0.55&#xA0;M). This latter solution (with slightly altered CHCl<sub>3</sub>:CH<sub>3</sub>OH:2&#xA0;M TEAB proportions), is correctly described by <xref rid="bib28" ref-type="bibr">Zou et&#xA0;al. (2007)</xref>, who also successfully used a more widely available type of glass bead for this experimental procedure.</p>
        <p>To return to PtdIns5<italic>P</italic> functions, in the cytosol its principal effect has been suggested to be to increase Akt activation (<xref rid="bib20" ref-type="bibr">Pendaries et&#xA0;al., 2006</xref>), perhaps by inhibiting its dephosphorylation (<xref rid="bib22" ref-type="bibr">Ramel et&#xA0;al., 2009</xref>) or the dephosphorylation of PtdIns(3,4,5)<italic>P</italic><sub>3</sub> (<xref rid="bib3" ref-type="bibr">Carricaburu et&#xA0;al., 2003</xref>). Recently two putative PtdIns5<italic>P</italic> effectors, Dok-1 and Dok-2 were described in T cells (<xref rid="bib11" ref-type="bibr">Guittard et&#xA0;al., 2009</xref>), and the significance of these will be an interesting area for future exploration. A better understood aspect of PtdIns5<italic>P</italic> function is in the nucleus, where ING-2 has been identified as an effector (<xref rid="bib10" ref-type="bibr">Gozani et&#xA0;al., 2003</xref>). Divecha's group have put together a convincing case that PtdIns5<italic>P</italic> 4-kinase II&#x3B2; regulates the levels of nuclear PtdIns5<italic>P</italic> (<xref rid="bib15" ref-type="bibr">Jones et&#xA0;al., 2006</xref>), whereby stressing cells activates p38 MAP kinase, which phosphorylates PtdIns5<italic>P</italic> 4-kinase II&#x3B2; on two Ser residues causing its inhibition, and thus PtdIns5<italic>P</italic> increases. This complements the demonstration that stress increases the nuclear localization of the PtdIns5<italic>P</italic>-generating enzyme Type I PtdIns(4,5)<italic>P</italic><sub>2</sub> 4-phosphatase (<xref rid="bib28" ref-type="bibr">Zou et&#xA0;al., 2007</xref>). So, what regulates the nuclear localization of PtdIns5<italic>P</italic> 4-kinase II&#x3B2;, and is this the only Type II enzyme involved? We have made some interesting observations in this context recently, which we will briefly summarize here.</p>
      </sec>
      <sec id="sec2.3">
        <title>PtdIns5<italic>P</italic> 4-kinases II&#x3B1; and II&#x3B2;</title>
        <p>Although there have been some indications that endogenous PtdIns5<italic>P</italic> 4-kinase II&#x3B1; may be partly nuclear (<xref rid="bib8 bib2" ref-type="bibr">Divecha et&#xA0;al., 1993; Boronenkov et&#xA0;al., 1998</xref>), extensive studies on transfected cells have shown that the II&#x3B1; and II&#x3B2; isoforms are respectively cytosolic and nuclear, with the latter being localized by a unique nuclear localization sequence consisting of an acidic &#x3B1;-helix (<xref rid="bib4 bib7" ref-type="bibr">Ciruela et&#xA0;al., 2000; Clarke et&#xA0;al., 2007</xref>). Moreover, tagging the endogenous PtdIns5<italic>P</italic> 4-kinase II&#x3B2; by genomic tagging in DT40 cells (see below) confirmed that the endogenous enzyme appeared to be entirely nuclear, within the limits of the cell fractionation procedure employed (<xref rid="bib24" ref-type="bibr">Richardson et&#xA0;al., 2007</xref>). However, a nuclear localization for PtdIns5<italic>P</italic> 4-kinase II&#x3B2; sat at odds with the phenotype of the knockout mouse (<xref rid="bib16" ref-type="bibr">Lamia et&#xA0;al., 2004</xref>) complemented by transfection studies with PtdIns5<italic>P</italic> 4-kinase II&#x3B2;, both of which pointed to a predominantly cytoplasmic role for this enzyme (<xref rid="bib3" ref-type="bibr">Carricaburu et&#xA0;al., 2003</xref>).</p>
        <p>We have recently used genomic tagging in DT40 cells to begin to resolve some of these contradictions and to throw a new light on the relationship between these two Type II PtdIns5<italic>P</italic> 4-kinase isoforms (M.W., N. Bond, J. Richardson, K. Lilley, R.F.I. and J.H.C unpublished observations). In brief, we have found that PtdIns5<italic>P</italic> 4-kinases II&#x3B1; and II&#x3B2; heterodimerize, such that a significant proportion of II&#x3B1; is nuclear. Moreover, the enzymic activity of the II&#x3B1; is much greater than that of II&#x3B2;, so it is possible that a, or the, major function of the II&#x3B2; isoform is simply to target the II&#x3B1; to the nucleus. This is particularly interesting in the light of the evidence, based on mRNA levels, that in most tissues, indeed, in all that were studied except spleen, the II&#x3B2; isoform is more highly expressed than the II&#x3B1; (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>).</p>
        <p>Note that spleen is a site of synthesis of B cells (of which DT40s are, indirectly, an example), and T cells, so it is interesting that, as described above, <xref rid="bib11" ref-type="bibr">Guittard et&#xA0;al. (2009)</xref> have recently discovered two new, cytoplasmic, putative PtdIns5<italic>P</italic> effectors in T cells. The spleen is also the site of synthesis of erythrocytes and platelets, from which PtdIns5<italic>P</italic> 4-kinase II&#x3B1; was first purified and cloned by <xref rid="bib1" ref-type="bibr">Boronenkov and Anderson (1995)</xref> and <xref rid="bib9" ref-type="bibr">Divecha et&#xA0;al. (1995)</xref> respectively. Another intriguing link between erythrocytes and PtdIns5<italic>P</italic> 4-kinase II&#x3B1; has emerged recently in a pair of &#x3B1;-thalassemic twins with very different &#x3B2;-globin gene expression levels, in which the only other gene showing a similar disparity in expression in their reticulocytes was PtdIns5<italic>P</italic> 4-kinase II&#x3B1; (<xref rid="bib27" ref-type="bibr">Wenning et&#xA0;al., 2009</xref>).</p>
        <p>This emphasis on PtdIns5<italic>P</italic> 4-kinase II&#x3B1; in blood cells makes a contrast with all other tissues so far&#xA0;investigated in this context, where PtdIns5<italic>P</italic> 4-kinase II&#x3B2; mRNA is dominant over that for PtdIns5<italic>P</italic> 4-kinase II&#x3B1; (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>). It throws open the possibility that in many tissues most PtdIns5<italic>P</italic> 4-kinase II&#x3B1; is nuclear, and this will be especially so in muscle and liver (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>). This in turn sheds an alternative light on the experiments discussed above where PtdIns5<italic>P</italic> 4-kinase II&#x3B2; levels were manipulated (<xref rid="bib3 bib16" ref-type="bibr">Carricaburu et&#xA0;al., 2003; Lamia et&#xA0;al., 2004</xref>), in that perhaps the major effect of decreasing PtdIns5<italic>P</italic> 4-kinase II&#x3B2; is to increase cytosolic II&#x3B1; because there is no II&#x3B2; to take it to the nucleus. Of course we don't yet know if II&#x3B1;/II&#x3B2; heterodimers are localized within the nucleus in the same place as II&#x3B2;/II&#x3B2; homodimers, nor whether they have distinct functions, and overall our discovery of this heterodimerization asks more questions than it answers. But that is what makes it interesting.</p>
      </sec>
      <sec id="sec2.4">
        <title>PtdIns5P 4-kinase II&#x3B3;</title>
        <p>This has been the &#x2018;Cinderella&#x2019; member of the family until recently, and we have been investigating some of its basic biology and biochemistry, which we summarize here.</p>
        <p>When first cloned by <xref rid="bib14" ref-type="bibr">Itoh et&#xA0;al. (1998)</xref>, PtdIns5<italic>P</italic> 4-kinase II&#x3B3; was described as being highly expressed in kidney, localized to the endoplasmic reticulum, and phosphorylated when cells were stimulated by mitogens. We have confirmed that kidney expresses PtdIns5<italic>P</italic> 4-kinase II&#x3B3; more highly than any other tissue &#x2013; as judged by mRNA levels, kidney is unique in expressing more PtdIns5<italic>P</italic> 4-kinase II&#x3B3; than PtdIns5<italic>P</italic> 4-kinase II&#x3B1; and II&#x3B2; combined (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>). Even more striking is the localization of expression within the kidney, as PtdIns5<italic>P</italic> 4-kinase II&#x3B3; is largely confined to epithelial cells in the thick ascending limb and the intercalated cells of the collecting duct (<xref rid="fig2" ref-type="fig">Fig.&#xA0;2</xref> and <xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>).</p>
        <p>The distribution of PtdIns5<italic>P</italic> 4-kinase II&#x3B3; in nervous tissue, the other type of tissue in which it is highly expressed (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>), shows a similar restricted and well defined expression in the brain and also the spinal cord (<xref rid="bib6" ref-type="bibr">Clarke et&#xA0;al., 2009</xref>). This expression is limited to neurons, particularly the cerebellar Purkinje cells, pyramidal cells of the hippocampus, large neuronal cell-types in the cerebral cortex including pyramidal cells, and mitral cells in the olfactory bulb, but is not expressed in cerebellar, hippocampal formation or olfactory bulb granule cells (<xref rid="bib6" ref-type="bibr">Clarke et&#xA0;al., 2009</xref>).</p>
        <p>These distinct and specific expression patterns in brain and kidney will eventually tell us something of its function, though at present this is difficult to guess. However, two other properties of PtdIns5<italic>P</italic> 4-kinase II&#x3B3; point a way forward in understanding what it does. Firstly, in both kidney (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>) and brain (<xref rid="bib6" ref-type="bibr">Clarke et&#xA0;al., 2009</xref>) it shows the same intracellular distribution: it appears to be associated with vesicles, which in kidney epithelial cells are concentrated towards the secreting end of the cells (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>).</p>
        <p>We do not yet know the nature of these vesicles. In neurons PtdIns5<italic>P</italic> 4-kinase II&#x3B3; shows a partial colocalization with markers of cellular compartments of the endomembrane trafficking pathway (<xref rid="bib6" ref-type="bibr">Clarke et&#xA0;al., 2009</xref>), and transfection experiments with mildly permeabilized HeLa cells showed a partial colocalization with Golgi markers such as GM130 and golgin 160, as well as the endosomal marker EEA1, but after more extensive cell permeabilization these correlations were decreased (<xref rid="bib6" ref-type="bibr">Clarke et&#xA0;al., 2009</xref>). In transfected kidney cell lines (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>), PtdIns5<italic>P</italic> 4-kinase II&#x3B3; was again partially colocalized with GM130, but not with endoplasmic reticulum or ERGIC markers, and the GM130 relationship survived Brefeldin A treatment of the cells.</p>
        <p>Together these data suggest a close association of PtdIns5<italic>P</italic> 4-kinase II&#x3B3; with vesicular cell trafficking linked with the Golgi apparatus. In the kidney this would be associated with the business of inserting and removing plasma membrane transporters and channels, and in the brain either trafficking of vesicles along neuronal processes or perhaps the delivery/insertion of channels and transporters to their correct locations. PtdIns(4,5)<italic>P</italic><sub>2</sub> is of course known to be associated with the regulation of activity and trafficking of ion channels and transporters, but returning to the low levels of PtdIns5<italic>P</italic> compared to PtdIns4<italic>P</italic> in cells plus the evidence discussed above for possible roles of PtdIns5<italic>P</italic> in other cellular functions, we think it much more likely that PtdIns5<italic>P</italic> is the active molecule in whatever vesicular processing/transporting events PtdIns5<italic>P</italic> 4-kinase II&#x3B3; is regulating.</p>
        <p>Secondly, there is another aspect of PtdIns5<italic>P</italic> 4-kinase II&#x3B3; biochemistry which may point to how it functions &#x2013; actually it is two properties that suggest the same thing. PtdIns5<italic>P</italic> 4-kinase II&#x3B3; is, when bacterially expressed, catalytically close to inactive (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>); it has even less activity than PtdIns5<italic>P</italic> 4-kinase II&#x3B2; (above). But when immunoprecipitated from eukaryotic cells, PtdIns5<italic>P</italic> 4-kinase II&#x3B3; does show some catalytic activity, which can be accounted for by its association with PtdIns5<italic>P</italic> 4-kinase II&#x3B1;, an association that we have demonstrated directly <italic>in vitro</italic> (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>). Thus we can see a parallel with the PtdIns5<italic>P</italic> 4-kinase II&#x3B1;/II&#x3B2; heterodimerization that we have discussed above, and our current working hypothesis for PtdIns5<italic>P</italic> 4-kinase II&#x3B3; is that it is associated with a sub-population of vesicles in the cell trafficking system, and by heterodimerization with PtdIns5<italic>P</italic> 4-kinase II&#x3B1; it targets the latter enzyme to the relevant vesicles, where it regulates PtdIns5<italic>P</italic> levels for a function yet to be defined (see above). We should note also that there is still the possibility that by associating with a Type I PtdIns4<italic>P</italic> 5-kinase activity (<xref rid="bib12" ref-type="bibr">Hinchliffe et&#xA0;al., 2002</xref>), PtdIns5<italic>P</italic> 4-kinase II&#x3B1; may also target one of these enzymes to the relevant vesicles (discussed further below), so PtdIns(4,5)<italic>P</italic><sub>2</sub> might yet be a relevant signal in this context too.</p>
        <p>So our recent data are painting a different picture of Type II PtdIns5<italic>P</italic> 4-kinase function and regulation from that which we have had before. We can suggest the possibility that PtdIns5<italic>P</italic> 4-kinase II&#x3B1; is the (possibly the only significantly) active enzyme of the three isoforms, and that it may have its own individual function(s) in cells. Additionally it can be targeted by the other isoforms, to the nucleus by PtdIns5<italic>P</italic> 4-kinase II&#x3B2;, or to trafficking/secretory vesicles by PtdIns5<italic>P</italic> 4-kinase II&#x3B3;. This picture paints a remarkable (and we suspect unique) relationship between three isoforms of the same lipid kinase family.</p>
      </sec>
      <sec id="sec2.5">
        <title>Association between Type I and Type II PtdIns<italic>P</italic> kinases</title>
        <p>Before leaving the subject of the heterodimerization of Type II PtdIns5<italic>P</italic> 4-kinases, another dimerization (or at least, association) needs discussing in this context, which is the association of PtdIns5P 4-kinase II&#x3B1; with Type I PtdIns4<italic>P</italic> 5-kinases. This binding is clearly documented both with transfected and endogenous Type I enzymes (<xref rid="bib12" ref-type="bibr">Hinchliffe et&#xA0;al., 2002</xref>). We do not yet know which structural domains of either partner (Type I or II) are involved in this interaction. The regions involved in heterodimerization between PtdIns5<italic>P</italic> 4-kinases II&#x3B1;, II&#x3B2;, and II&#x3B3; is fairly certain: the &#x3B2; isoform is a homodimer in the crystals used for structural analysis, with the interaction between the monomers being due to two opposing &#x3B2;-pleated sheets (<xref rid="bib23" ref-type="bibr">Rao et&#xA0;al., 1998</xref>), and this part of the enzyme is identical in&#xA0;all three isoforms. But a crucial question is whether a hetero (or homo) dimerized Type II PtdIns5<italic>P</italic> 4-kinase is capable of also associating with a Type I PtdInd4<italic>P</italic> 5-kinase, or, put another way, does the Type I/II association involve the same region of the enzymes so that a Type II enzyme is compelled to associate either with a Type I or a Type II PtdIns<italic>P</italic> kinase, but not with both?</p>
        <p>This is not a trivial question, as one of the interesting ideas that we discussed above is that the localization of the highly active Type II&#x3B1; PtdIns5<italic>P</italic> 4-kinase may be governed entirely by the relative levels of expression of the II&#x3B2; and II&#x3B3; isoforms, levels that can vary greatly between tissues (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>). If we have to factor into that idea the relative levels of the three Type I PtdIns4<italic>P</italic> 5-kinases, each of which can interact with the Type II&#x3B1; PtdIns5<italic>P</italic> 4-kinase (<xref rid="bib12" ref-type="bibr">Hinchliffe et&#xA0;al., 2002</xref>) (and we do not yet know if Type II&#x3B2; or II&#x3B3; can interact with Type I activities), we have a very complex picture. Indeed, such a proposal would seem to make a nonsense of the above idea that relative levels of the three Type II isoforms has physiological relevance in dictating their localization, and the whole process of PtdIns<italic>P</italic> kinases associating would have to be tightly and complicatedly regulated. We should add that, when pulling down PtdIns5<italic>P</italic> 4-kinase II&#x3B2; from DT40 cells (above) we did not detect any Type I isoforms by mass spectroscopy, so any Type I/II interaction must be of lower affinity than Type II/II interactions. Overall we feel that a more likely idea is that the domains by which Type II enzymes interact with each other (<xref rid="bib23" ref-type="bibr">Rao et&#xA0;al., 1998</xref>) are different from those that PtdIns5<italic>P</italic> 4-kinase II&#x3B1; uses to associate with Type I enzymes, and so a Type II PtdIns<italic>P</italic> 4-kinase homo or heterodimer can additionally associate with a (two?) Type I PtdIns4<italic>P</italic> 5-kinase enzyme molecule(s). The functional consequences of this latter association still elude us.</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Summary</title>
      <p>Our recent studies of the Type II PtdIns5<italic>P</italic> 4-kinases have revealed that the Type II&#x3B1; isoform is very much more active than the II&#x3B2; or II&#x3B3; isoforms, and that it can (and does physiologically) heterodimerize with them. This suggests the idea that the Type II&#x3B1; enzyme is targeted to the nucleus (by dimerization with Type II&#x3B2;), to secretory/transport vesicles (by dimerization with Type II&#x3B3;), or to the cytoplasm (as a homodimer), with the relative proportions of PtdIns5<italic>P</italic> 4-kinase activity at these localizations being regulated by the relative amounts of the three Type II isoforms expressed in any cell. The targeting to vesicles by PtdIns5<italic>P</italic> 4-kinase II&#x3B3; is likely to be of particular significance in epithelial cells in specific regions of the kidney tubules and in a sub-population of neurons in the brain and the spinal cord. The relationship between this dimerization between Type II PtdIns5<italic>P</italic> 4-kinase isoforms and the known ability of Type II&#x3B1; PtdIns5<italic>P</italic> 4-kinase to associate with Type I PtdIns4<italic>P</italic> 5-kinases remains to be explored.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The work from our laboratory described above was funded by a Programme Grant from the Wellcome Trust.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boronenkov</surname>
              <given-names>I.V.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>The sequence of phosphatidylinositol-4-phosphate 5-kinase defines a novel family of lipid kinases</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>2881</fpage>
          <lpage>2884</lpage>
          <pub-id pub-id-type="pmid">7852364</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boronenkov</surname>
              <given-names>I.V.</given-names>
            </name>
            <name>
              <surname>Loijens</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Umeda</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors</article-title>
          <source>Mol Biol Cell</source>
          <year>1998</year>
          <volume>9</volume>
          <fpage>3547</fpage>
          <lpage>3560</lpage>
          <pub-id pub-id-type="pmid">9843587</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carricaburu</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Lamia</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Favereaux</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Payrastre</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Cantley</surname>
              <given-names>L.C.</given-names>
            </name>
          </person-group>
          <article-title>The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>9867</fpage>
          <lpage>9872</lpage>
          <pub-id pub-id-type="pmid">12897244</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciruela</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hinchliffe</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Divecha</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear targeting of the &#x3B2; isoform of Type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its &#x3B1;-helix 7</article-title>
          <source>Biochem J</source>
          <year>2000</year>
          <volume>364</volume>
          <fpage>587</fpage>
          <lpage>591</lpage>
          <pub-id pub-id-type="pmid">10698683</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Emson</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Localization of phosphatidylinositol phosphate kinase IIgamma in kidney to a membrane trafficking compartment within specialized cells of the nephron</article-title>
          <source>Am J Physiol Renal Physiol</source>
          <year>2008</year>
          <volume>295</volume>
          <fpage>F1422</fpage>
          <lpage>F1430</lpage>
          <pub-id pub-id-type="pmid">18753295</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Emson</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Distribution and neuronal expression of phosphatidylinositol phosphate kinase II&#x3B3; in the mouse brain</article-title>
          <source>J Comp Neurol</source>
          <year>2009</year>
          <volume>517</volume>
          <fpage>296</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">19757494</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Hinchliffe</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Type II PIP kinases: location, regulation and function</article-title>
          <source>Biochem Soc Symp</source>
          <year>2007</year>
          <volume>74</volume>
          <fpage>149</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">17233588</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Divecha</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Rhee</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Letcher</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Phosphoinositide signalling enzymes in rat liver nuclei: phosphoinositidase C isoform beta 1 is specifically, but not predominantly, located in the nucleus</article-title>
          <source>Biochem J</source>
          <year>1993</year>
          <volume>289</volume>
          <fpage>617</fpage>
          <lpage>620</lpage>
          <pub-id pub-id-type="pmid">8382043</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Divecha</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Truong</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Hsuan</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Hinchliffe</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>The cloning and sequence of the C isoform of PtdIns4P 5-kinase</article-title>
          <source>Biochem J</source>
          <year>1995</year>
          <volume>309</volume>
          <fpage>715</fpage>
          <lpage>719</lpage>
          <pub-id pub-id-type="pmid">7639683</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gozani</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Karuman</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Ivanov</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cha</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lugovskoy</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor</article-title>
          <source>Cell</source>
          <year>2003</year>
          <volume>114</volume>
          <fpage>99</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">12859901</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guittard</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Gerard</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dupuis-Coronas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tronchere</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mortier</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Favre</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells</article-title>
          <source>J Immunol</source>
          <year>2009</year>
          <volume>182</volume>
          <fpage>3974</fpage>
          <lpage>3978</lpage>
          <pub-id pub-id-type="pmid">19299694</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinchliffe</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Giudici</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Letcher</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Type IIalpha phosphatidylinositol phosphate kinase associates with the plasma membrane via interaction with type I isoforms</article-title>
          <source>Biochem J</source>
          <year>2002</year>
          <volume>363</volume>
          <fpage>563</fpage>
          <lpage>570</lpage>
          <pub-id pub-id-type="pmid">11964157</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Lloyd-Burton</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>C.H.Y.</given-names>
            </name>
            <name>
              <surname>Letcher</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Schell</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>The regulation and function of inositol 1,4,5-trisphosphate 3-kinases</article-title>
          <source>Adv Enzyme Regul</source>
          <year>2006</year>
          <volume>46</volume>
          <fpage>314</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">16857241</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Itoh</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ijuin</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Takenawa</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>A novel phosphatidylinositol-5-phosphate 4-kinase (phosphatidylinositol- phosphate kinase IIgamma) is phosphorylated in the endoplasmic reticulum in response to mitogenic signals</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>20292</fpage>
          <lpage>20299</lpage>
          <pub-id pub-id-type="pmid">9685379</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Bultsma</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Keune</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Halstead</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Elouarrat</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mohammed</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear PtdIns5P as a transducer of stress signaling: an in vivo role for PIP4Kbeta</article-title>
          <source>Mol Cell</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>685</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="pmid">16949365</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamia</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Peroni</surname>
              <given-names>O.D.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Y.B.</given-names>
            </name>
            <name>
              <surname>Rameh</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Cantley</surname>
              <given-names>L.C.</given-names>
            </name>
          </person-group>
          <article-title>Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-/- mice</article-title>
          <source>Mol Cell Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>5080</fpage>
          <lpage>5087</lpage>
          <pub-id pub-id-type="pmid">15143198</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lecompte</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Poch</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Laporte</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>PtdIns5P regulation through evolution: roles in membrane trafficking?</article-title>
          <source>Trends Biochem Sci</source>
          <year>2008</year>
          <volume>33</volume>
          <fpage>453</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="pmid">18774718</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Hinchliffe</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Ciruela</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Letcher</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Thrombin stimulation of platelets causes an increase in phosphatidylinositol 5-phosphate revealed by mass assay</article-title>
          <source>FEBS Lett</source>
          <year>2000</year>
          <volume>475</volume>
          <fpage>57</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">10854858</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pagliarini</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Worby</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>A PTEN-like phosphatase with a novel substrate specificity</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>38590</fpage>
          <lpage>38596</lpage>
          <pub-id pub-id-type="pmid">15247229</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pendaries</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tronchere</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Arbibe</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mounier</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gozani</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Cantley</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>PtdIns(5)P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection</article-title>
          <source>EMBO J</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>1024</fpage>
          <lpage>1034</lpage>
          <pub-id pub-id-type="pmid">16482216</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rameh</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Tolias</surname>
              <given-names>K.F.</given-names>
            </name>
            <name>
              <surname>Duckworth</surname>
              <given-names>B.C.</given-names>
            </name>
            <name>
              <surname>Cantley</surname>
              <given-names>L.C.</given-names>
            </name>
          </person-group>
          <article-title>A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>390</volume>
          <fpage>192</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">9367159</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lagarrigue</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Dupuis-Coronas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chicanne</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Leslie</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gaits-Iacovoni</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>PtdIns5P protects Akt from dephosphorylation through PP2A inhibition</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2009</year>
          <volume>387</volume>
          <fpage>127</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">19576174</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>V.D.</given-names>
            </name>
            <name>
              <surname>Misra</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Boronenkov</surname>
              <given-names>I.V.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Hurley</surname>
              <given-names>J.H.</given-names>
            </name>
          </person-group>
          <article-title>Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation</article-title>
          <source>Cell</source>
          <year>1998</year>
          <volume>94</volume>
          <fpage>829</fpage>
          <lpage>839</lpage>
          <pub-id pub-id-type="pmid">9753329</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Genomic tagging of endogenous type IIbeta phosphatidylinositol 5-phosphate 4-kinase in DT40 cells reveals a nuclear localisation</article-title>
          <source>Cell Signal</source>
          <year>2007</year>
          <volume>19</volume>
          <fpage>1309</fpage>
          <lpage>1314</lpage>
          <pub-id pub-id-type="pmid">17303380</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>H.F.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Letcher</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Effect of lipid kinase expression and cellular stimuli on phosphatidylinositol 5-phosphate levels in mammalian cell lines</article-title>
          <source>FEBS Lett</source>
          <year>2005</year>
          <volume>579</volume>
          <fpage>2868</fpage>
          <lpage>2872</lpage>
          <pub-id pub-id-type="pmid">15876433</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ungewickell</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hugge</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kisseleva</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>18854</fpage>
          <lpage>18859</lpage>
          <pub-id pub-id-type="pmid">16365287</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wenning</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Mello</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Andrade</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Lanaro</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Albuquerque</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Saad</surname>
              <given-names>S.O.</given-names>
            </name>
          </person-group>
          <article-title>PIP4KIIA and beta-globin: transcripts differentially expressed in reticulocytes and associated with High levels of Hb H in two Siblings with Hb H Disease</article-title>
          <source>Eur J Haematol</source>
          <year>2009</year>
          <volume>83</volume>
          <fpage>490</fpage>
          <lpage>493</lpage>
          <pub-id pub-id-type="pmid">19656170</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Marjanovic</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kisseleva</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Majerus</surname>
              <given-names>P.W.</given-names>
            </name>
          </person-group>
          <article-title>Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>16834</fpage>
          <lpage>16839</lpage>
          <pub-id pub-id-type="pmid">17940011</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Fig.&#xA0;1</label>
      <caption>
        <p>The PtdIns<italic>P</italic> kinases. The inositol lipids and kinases that are the principal topics of discussion in this review are illustrated here. EC Numbers: Type I PtdIns4<italic>P</italic> 5-kinase, EC 2.7.1.68; Type II PtdIns5<italic>P</italic> 4-kinase, EC 2.7.1.149; PtdIns(4,5)<italic>P</italic><sub>2</sub> 4-phosphatase, EC 3.1.3.78.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig.&#xA0;2</label>
      <caption>
        <p>PtdIns5<italic>P</italic> 4-kinase II&#x3B3; expression in the adult mouse kidney. An antibody specific to PtdIns5<italic>P</italic> 4-kinase II&#x3B3; was used in tissue immunohistochemistry to identify endogenous expression in kidney sections; for details see (<xref rid="bib5" ref-type="bibr">Clarke et&#xA0;al., 2008</xref>). A) PtdIns5<italic>P</italic> 4-kinase II&#x3B3; in a whole saggital kidney section (scale bar&#xA0;=&#xA0;1&#xA0;mm). B) PtdIns5<italic>P</italic> 4-kinase II&#x3B3; in a representative strip showing differential PtdIns5<italic>P</italic> 4-kinase II&#x3B3; expression from outer capsule to calyx (scale bar&#xA0;=&#xA0;250&#xA0;&#x3BC;m). C) Inset slides show PtdIns5<italic>P</italic> 4-kinase II&#x3B3; in the cortex, outer and inner medulla. The PtdIns5<italic>P</italic> 4-kinase II&#x3B3; signal is restricted to specific cells within these regions (scale bar&#xA0;=&#xA0;40&#xA0;&#x3BC;m).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
  </floats-wrap>
</article>
